Difference between revisions of "Alpha-2 macroglobulin"
m (Alpha-2 macroglobulin (FXIIIa) moved to Alpha-2 macroglobulin) |
|||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | + | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" {infobox header}| '''{{PAGENAME}}''' |
− | |||
|- | |- | ||
− | | align="center" colspan="2" bgcolor="#ffffff" | | + | | align="center" colspan="2" bgcolor="#ffffff" | |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 46: | Line 45: | ||
| | | | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:FXIIIa|*]] | [[Category:FXIIIa|*]] |
Latest revision as of 10:25, 10 March 2015
Substrate peptide name | Alpha-2 macroglobulin |
Synonyms | - |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Extracellular; plasma |
Swissprot ID | P01023 |
Reactive glutamines | Q670 |
Reactive lysines | - |
Substrate sequence | MCPQLQQYEMHG |
Structure | No available crystal structure |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:6169549 |
Notes | |